Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Cannabis Genotyping Pipeline

EF 2018-19

Résumé
Greenway Greenhouse Cannabis Corporation (Greenway) is a vertically integrated medicinal cannabis*producer, recently spun off from its parent company, Sunrite Greenhouses Ltd., which has over 45 years of*experience in commercial horticulture and over 4 million square feet of hydroponic production area (0.5*million sq. ft. of this is dedicated to Greenway). Greenway also has access to diverse and unique germplasm*(i.e. seed and tissue) resources, including a collection of 100 high-value cannabis strains gifted legally as seeds*by an expert breeder. Although Greenway has substantial horticultural expertise and infrastructure, it lacks*research capacity in genetics and therefore seeks an academic partner to collaborate on development of a novel,*rapid system for genetically characterizing its germplasm. This will allow Greenway to rationally select a*subset of its strains for further development, breeding, and commercialization. This will also lay a foundation*for genetic mapping of key traits, variety protection, and quality assurance.*To accomplish the collaborative objective of developing a rapid, DNA-based method for defining the*relatedness of cannabis strains, we will leverage DNA sequence information already in the public domain for*1300 cannabis strains, and identify a set of 384 genetic markers (SNPs, single-nucleotide polymorphisms) that*will be used in a genotyping-by-sequencing assay to produce genetic fingerprints for each strain. These genetic*fingerprints will be obtained for the 100 high-value strains and from known strains, to identify clusters of*related germplasm. These clusters will also be compared to information collected about the growth and (in the*future) the chemical properties of each strain. The minimum number of informative markers will be*determined to further streamline the protocol in the future. These results will form the basis of future*collaborations including development of diverse breeding and mapping populations.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
533321-2018
Name nom
Deyholos, Michael
Department département
Okanagan - Biology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
103
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Plant production and plant primary products
Area of application fr
Production végétale et produits végétaux primaires
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Partie
1
Nb partie
1
Application title
Cannabis Genotyping Pipeline
Keyword
NSERC
Application summary
Greenway Greenhouse Cannabis Corporation (Greenway) is a vertically integrated medicinal cannabis*producer, recently spun off from its parent company, Sunrite Greenhouses Ltd., which has over 45 years of*experience in commercial horticulture and over 4 million square feet of hydroponic production area (0.5*million sq. ft. of this is dedicated to Greenway). Greenway also has access to diverse and unique germplasm*(i.e. seed and tissue) resources, including a collection of 100 high-value cannabis strains gifted legally as seeds*by an expert breeder. Although Greenway has substantial horticultural expertise and infrastructure, it lacks*research capacity in genetics and therefore seeks an academic partner to collaborate on development of a novel,*rapid system for genetically characterizing its germplasm. This will allow Greenway to rationally select a*subset of its strains for further development, breeding, and commercialization. This will also lay a foundation*for genetic mapping of key traits, variety protection, and quality assurance.*To accomplish the collaborative objective of developing a rapid, DNA-based method for defining the*relatedness of cannabis strains, we will leverage DNA sequence information already in the public domain for*1300 cannabis strains, and identify a set of 384 genetic markers (SNPs, single-nucleotide polymorphisms) that*will be used in a genotyping-by-sequencing assay to produce genetic fingerprints for each strain. These genetic*fingerprints will be obtained for the 100 high-value strains and from known strains, to identify clusters of*related germplasm. These clusters will also be compared to information collected about the growth and (in the*future) the chemical properties of each strain. The minimum number of informative markers will be*determined to further streamline the protocol in the future. These results will form the basis of future*collaborations including development of diverse breeding and mapping populations.